Avantax Planning Partners’s T2 Biosystems, Inc TTOO Stock Holding History

Avantax Planning Partners’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-102	Closed	-$2.25K	–	388
2023 Q3	$2.25K	Buy	+102	New	+$2.66K	﹤0.01%	362
2022 Q4	–	Sell	-22	Closed	-$12K	–	381
2022 Q3	$12K	Hold	22	–	–	﹤0.01%	342
2022 Q2	$18K	Hold	22	–	–	﹤0.01%	338
2022 Q1	$58K	Hold	22	–	–	﹤0.01%	349
2021 Q4	$57K	Buy	22 +14	+175%	+$48.7K	﹤0.01%	346
2021 Q3	$37K	Hold	8	–	–	﹤0.01%	334
2021 Q2	$48K	Hold	8	–	–	﹤0.01%	321
2021 Q1	$65K	Buy	+8	New	+$84.7K	﹤0.01%	311

Other funds holding TTOO

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Avantax Planning Partners's TTOO Position: Q4 2023 in Review

Avantax Planning Partners sold out of T2 Biosystems, Inc (TTOO) in Q4 2023, closing a stake of 102 shares — an estimated $2.25K sold.

Avantax Planning Partners first reported a position in TTOO in Q1 2021 and held it in 8 quarters. The position peaked at $65K in Q1 2021. 21 funds tracked by Wall St. Rank hold TTOO as of Q4 2023.

Avantax Planning Partners reported no remaining T2 Biosystems, Inc position as of Q4 2023 after selling out during the quarter.
Avantax Planning Partners sold 102 T2 Biosystems, Inc shares in Q4 2023, an estimated $2.25K.
Avantax Planning Partners first reported a position in T2 Biosystems, Inc in Q1 2021 and held it in 8 quarters.
Avantax Planning Partners's T2 Biosystems, Inc position peaked at $65K in Q1 2021.
21 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2023.

Based on Avantax Planning Partners's 13F filing for Q4 2023, filed 9 Feb 2024.